Ballentine Partners, LLC Merck & Co., Inc. Transaction History

Ballentine Partners, LLC

  • $5.81 Billion
  • Q3 2024

A detailed history of Ballentine Partners, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Ballentine Partners, LLC holds 66,176 shares of MRK stock, worth $6.49 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares
66,176
Previous 74,179 10.79%
Holding current value
$6.49 Million
Previous $9.18 Million 18.17%
% of portfolio
0.13%
Previous 0.17%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024
SELL
$111.15 - $128.97 $889,533 - $1.03 Million
-8,003 Reduced 10.79%
66,176 $7.51 Million
Q2 2024

Aug 06, 2024
BUY
$123.8 - $132.96 $748,247 - $803,610
6,044 Added 8.87%
74,179 $9.18 Million
Q1 2024

Apr 11, 2024
BUY
$113.24 - $131.95 $531,548 - $619,373
4,694 Added 7.4%
68,135 $8.99 Million
Q4 2023

Jan 23, 2024
BUY
$100.18 - $109.02 $970,744 - $1.06 Million
9,690 Added 18.03%
63,441 $6.92 Million
Q3 2023

Oct 19, 2023
SELL
$102.95 - $114.33 $96,978 - $107,698
-942 Reduced 1.72%
53,751 $5.53 Million
Q2 2023

Jul 26, 2023
SELL
$108.61 - $118.38 $242,851 - $264,697
-2,236 Reduced 3.93%
54,693 $6.31 Million
Q1 2023

Apr 27, 2023
BUY
$102.94 - $114.86 $1.56 Million - $1.74 Million
15,114 Added 36.14%
56,929 $6.06 Million
Q4 2022

Jan 27, 2023
BUY
$87.44 - $112.11 $392,080 - $502,701
4,484 Added 12.01%
41,815 $0
Q3 2022

Oct 26, 2022
BUY
$84.53 - $94.96 $329,413 - $370,059
3,897 Added 11.66%
37,331 $3.22 Million
Q2 2022

Aug 09, 2022
BUY
$83.49 - $94.64 $121,310 - $137,511
1,453 Added 4.54%
33,434 $3.05 Million
Q1 2022

May 05, 2022
BUY
$73.51 - $82.4 $46,164 - $51,747
628 Added 2.0%
31,981 $2.62 Million
Q4 2021

Feb 14, 2022
BUY
$72.28 - $90.54 $53,414 - $66,909
739 Added 2.41%
31,353 $2.4 Million
Q3 2021

Oct 27, 2021
BUY
$71.68 - $78.83 $3,655 - $4,020
51 Added 0.17%
30,614 $2.3 Million
Q2 2021

Aug 12, 2021
SELL
$70.31 - $77.77 $80,575 - $89,124
-1,146 Reduced 3.61%
30,563 $2.38 Million
Q1 2021

May 11, 2021
SELL
$68.86 - $81.11 $143,022 - $168,465
-2,077 Reduced 6.15%
31,709 $2.44 Million
Q4 2020

Jan 25, 2021
SELL
$71.77 - $79.65 $121,506 - $134,847
-1,693 Reduced 4.77%
33,786 $2.76 Million
Q3 2020

Oct 22, 2020
BUY
$73.18 - $82.95 $364,655 - $413,339
4,983 Added 16.34%
35,479 $2.94 Million
Q2 2020

Jul 31, 2020
BUY
$70.42 - $80.13 $33,872 - $38,542
481 Added 1.6%
30,496 $2.36 Million
Q1 2020

Apr 23, 2020
BUY
$63.36 - $87.82 $16,410 - $22,745
259 Added 0.87%
30,015 $2.31 Million
Q4 2019

Jan 22, 2020
BUY
$77.58 - $87.54 $9,309 - $10,504
120 Added 0.4%
29,756 $2.71 Million
Q3 2019

Oct 21, 2019
BUY
$76.08 - $82.93 $782,254 - $852,686
10,282 Added 53.13%
29,636 $2.5 Million
Q2 2019

Jul 25, 2019
BUY
$69.84 - $81.59 $246,255 - $287,686
3,526 Added 22.28%
19,354 $1.62 Million
Q1 2019

May 09, 2019
SELL
$69.58 - $79.36 $7,723 - $8,808
-111 Reduced 0.7%
15,828 $1.32 Million
Q4 2018

Feb 04, 2019
SELL
$65.24 - $75.71 $145,550 - $168,909
-2,231 Reduced 12.28%
15,939 $1.22 Million
Q3 2018

Oct 30, 2018
BUY
$57.69 - $67.84 $51,517 - $60,581
893 Added 5.17%
18,170 $1.29 Million
Q2 2018

Jul 19, 2018
BUY
$50.83 - $59.72 $58,251 - $68,439
1,146 Added 7.1%
17,277 $1.05 Million
Q1 2018

Apr 26, 2018
SELL
$50.96 - $59.23 $158,332 - $184,027
-3,107 Reduced 16.15%
16,131 $879,000
Q4 2017

Feb 02, 2018
SELL
$51.62 - $61.64 $198,685 - $237,252
-3,849 Reduced 16.67%
19,238 $1.08 Million
Q3 2017

Nov 06, 2017
BUY
$58.67 - $63.13 $1.35 Million - $1.46 Million
23,087
23,087 $1.48 Million

Others Institutions Holding MRK

# of Institutions
3,827
Shares Held
1.87B
Call Options Held
15.6M
Put Options Held
13.7M
View Full List

About Merck & Co., Inc.

MRK Quotes by TradingView
  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $248B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Ballentine Partners, LLC Portfolio

Follow Ballentine Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ballentine Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ballentine Partners, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email